PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Chart, page-2442

  1. 4,351 Posts.
    lightbulb Created with Sketch. 6891
    JT - I like your attitude.

    As I have said, I feel its like going down a funnel....we are getting closer to getting this IND. Will it happen this round? I can only wish. (If I cross me fingers any more tightly I might get arthritis of the finger joints and will find myself on both sides of the fence...investor AND patient). Is there some sorta chance that we will still have one more loop to go through? I hope not, but there probably is a small chance.


    Yes its a big hurdle...I think once we pass this there are still hurdles to pass but it will be a case of just getting on with it, monitoring and getting through. The best news for us was that the FDA approved our trial design initially and that was a close carbon copy to our Phase II. It could have been a stack more onerous, it could've had a competitor arm. It could have involved even more patients. We have the same Primary Endpoint. Its a rehash (but on a larger scale) of our Phase II. That was a sigh of collective relief.

    Longer term attitude does it for me on this one, the scope and the eventual potential is magnificent (my views).




    Indeed good luck to us holders at this important time.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.